doi:10.1002/tre.563Culley CarsonRoger KirbyTrends in Urology & Men's HealthCarson CC, Kirby R: Prostate cancer and testosterone replacement therapy: what is the risk? J Urol 2015; 194: 1527-8.
Have you been diagnosed with low T and are you on testosterone replacement therapy (TRT)? Do you know if you are at risk for prostate cancer or are on Active Surveillance (AS)? Have you been treated for prostate cancer in the past? If you answered yes to any of these, it will ...
Volume 96, Issue 4, pages 471–472, September 2005 Additional Information How to Cite Kirby, R. and Gould, D. (2005), Testosterone replacement therapy in hypogonadal men and prostate cancer risk. BJU International, 96: 471–472. doi: 10.1111/j.1464-410X.2005.05665.x Author Information Depar...
This phase IV trial studies the effects of testosterone replacement therapy (TRT) on treatment outcomes in hypogonadal men with prostate cancer that has not spread to other parts of the body (localized) and who are on active surveillance (AS). AS in prostate cancer involves closely watching the...
Re: Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer DF Penson - 《Journal of Urology》 被引量: 0发表: 2018年 Leptin is associated with increased prostate cancer risk: a nested case-referent study. A Western lifestyle has been implicated in the pathogenesis ...
CONCLUSIONS There appears to be no change in overall cancer risk for men utilizing long term testosterone replacement therapy. There may be a decrease in prostate cancer risk for men on TRT.doi:10.1016/j.juro.2013.02.2984Eisenberg, Michael
Prostate-specific antigen testing in hypogonadism: implications for the safety of testosterone-replacement therapy. Hypogonadal men have lower prostate volumes and serum prostate-specific antigen (PSA) levels than age-matched controls. When present, prostate cancer in hy... DC Gould,MR Feneley,RS Kirb...
He will first measure your current testosterone levels and then provide you with your own personalized hormone replacement treatment plan suited for your needs. Contact Dr. Terlinsky today. Does Bioidentical Testosterone Replacement Cause Prostate Cancer? In a word, no. Bioidentical testosterone is ...
To explore the practice and attitudes of uro-oncologists in the UK regarding monitoring testosterone levels and the use of testosterone replacement therapy (TRT) in their prostate cancer patients treated with androgen deprivation therapy (ADT).An expert-devised online questionnaire was completed by memb...
are commonly used as a testosterone replacement therapy for patients with low testosterone by drawing up testosterone cypionate doses from a vial, then administering with a syringe. Azmiro provides an FDA-approved prefilled option now available as a 200 mg/mL single dose syringe. Safety and effic...